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ABSTRACT: The aging of humanity is about to experience a radical
change as the demographic transformation to an older world is approach-
ing its final stage. In recent decades, scientists have learned enough about
the biological aging processes that many believe it will become possible
to slow aging in humans. We contend that the social, economic, and
health benefits that would result from such advances may be thought of
as “longevity dividends,” and that they should be aggressively pursued
as the new approach to health promotion and disease prevention in the
21st century. The time has arrived for governments and national and in-
ternational healthcare organizations to make research into healthy aging
a major research priority.
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Aging for both populations and individuals is on the verge of a new era.
Humans are approaching old age in unprecedented numbers as a result of large
baby-boom cohorts born in the middle of the 20th century that are approaching
traditional retirement ages. Increases in the prevalence of age-related disease,
frailty, and disability are visible harbingers of the potential costs and social
burdens arising from this historic demographic shift. Advances in the scien-
tific knowledge of aging, however, have now created new opportunities that
may allow us and those that follow to live healthier and longer lives than our
predecessors. We have reached a historical moment as scientists learn enough
about aging to allow us to postpone a wide range of fatal and disabling diseases
expressed throughout the life span, the result of which would be health and
economic benefits for current and all future generations.
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Why are we so optimistic now? The primary reason is that science has
revealed that aging is not the immutable process it was once thought to be.
Interventions at a variety of genetic, cellular, physiological, nutritional, and
behavioral levels not only increase longevity in laboratory organisms, but also
dramatically increase the duration of disease-free life. The realization that
some humans retain their physical and mental functioning for more than a cen-
tury suggests that genes associated with the extension of healthy life already
exist within the human genome. Biogerontologists have now gone from merely
describing cellular aging and cell death to manipulating the mechanisms re-
sponsible for these phenomena. Important strides have also been made toward
understanding the effects of hormones on cellular pathways that influence the
rate of aging. Since these pathways have similar effects in both humans and
laboratory organisms, intervention strategies can be evaluated quickly, in short-
lived animals, to find the ones most likely to work in humans. In short, we now
believe that extending the duration of healthy life in humans by slowing down
the processes of aging is a scientifically plausible goal, and adequate funding
in this area might well lead to dramatic advances in preventive medicine and
public health within the next few decades.
Even a minor deceleration in the rate of human aging could have profound
benefits for individuals and societies. Because prolonged, chronic illness is a
powerful driver of medical costs, enormous cost savings would be achieved
if mortality and morbidity could be compressed within a shorter duration
of time at the end of life. At least some of the manipulations that appear
to slow aging in animal models do just this, maintaining excellent physical
and cognitive function well beyond the usual ages at which illness and dis-
ability start to affect most untreated individuals. In fact, aging interventions
have the potential to do what no surgical procedure, behavior modification,
or cure for any one major fatal disease can do; namely, extend youthful vigor
throughout the life span. Extending the duration of physical and mental capac-
ity would permit people to remain in the labor force longer, amass more income
and savings, and thereby lessen the effect of shifting demographics on age-
based entitlement programs, with a net benefit to national economies. The
combined social, economic, and health bonuses accruing from a slowing of
the rate of aging is what we call the longevity dividend—benefits that might
begin with those now alive, and then continue for all generations that follow.
We now have good reasons to think that slowing aging in humans is sci-
entifically plausible and, given sufficient research investment, might prove to
be within our technical grasp in the foreseeable future. There are a number of
compelling reasons why this effort should now be aggressively pursued: (1) the
costs, to individuals and to society, of debilitating late-life illnesses are already
increasing in many countries as the population of elderly people mounts to
unprecedented levels, leading to escalating healthcare costs; (2) compressing
mortality and morbidity into a shorter duration of time at the end of life will pay
substantial health and financial dividends for members of the first generation
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to which they can be applied, dividends that will be compounded as new
generations benefit from existing and expanding technological advances; and
(3) a modest deceleration in the rate of biological aging would produce the
equivalent of simultaneous major breakthroughs against every single fatal and
non-fatal disease and disorder associated with growing older.
The time has arrived for governments and national and international health-
care organizations to make research into healthy aging a major research priority,
exploiting new discoveries towards the goal of manipulating the aging rate to
prevent or postpone multiple forms of late-life illnesses and disabilities. We
look forward to developing a national and international strategy that will lead
to the permanent extension of healthy life that would result from a successful
effort to slow the rate of aging.
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